Vera Therapeutics Inc. has announced new compensation terms under its Inducement Plan, following the grant of inducement awards by the company's Compensation Committee on July 6, 2025. These awards include non-qualified stock options for 133,500 shares of Class A common stock, with an exercise price of $24.00 per share, and restricted stock units (RSUs) for 73,695 shares. The stock options will vest over four years, with 25% vesting one year after the vesting commencement date, and the remainder vesting monthly over the next 36 months. The RSUs will also vest over four years, with 25% vesting annually starting from August 20, 2025. These grants, made in accordance with Nasdaq Listing Rule 5635(c)(4), are part of the company's efforts to attract new talent.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。